← Browse by Condition
Medical Condition

prostatic diseases

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT06785636 Phase 1, Phase 2
Recruiting

Open-Label Study of Pocenbrodib Alone and in Combination With Abiraterone Acetate, Olaparib, or 177Lu-PSMA-617

Enrollment
252 pts
Location
United States
Sponsor
Pathos AI, Inc.
View Trial →